Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP2 | P08253 | 9/20 | 0.66 |
| ▸ | MMP9 | P14780 | 7/20 | 0.66 |
| ▸ | ADAMTS4 | O75173 | 3/20 | 0.61 |
| ▸ | MMP13 | P45452 | 3/20 | 0.55 |
| ▸ | ADAMTS5 | Q9UNA0 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.55 |
| ▸ | MAPT | P10636 | 1/20 | 0.55 |
| ▸ | POLB | P06746 | 1/20 | 0.55 |
| ▸ | MMP1 | P03956 | 1/20 | 0.55 |
| ▸ | MMP3 | P08254 | 1/20 | 0.55 |
| ▸ | MMP7 | P09237 | 1/20 | 0.55 |
| ▸ | ITGAV | P06756 | 1/20 | 0.53 |
| ▸ | CTSL | P07711 | 2/20 | 0.51 |
| ▸ | CTSS | P25774 | 2/20 | 0.51 |
| ▸ | CTSK | P43235 | 2/20 | 0.51 |
| ▸ | CTSB | P07858 | 1/20 | 0.51 |
| ▸ | CNR1 | P21554 | 1/20 | 0.50 |
| ▸ | CNR2 | P34972 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL485675 | 1.00 | MMP2 (0.66) | MMP2MMP9ADAMTS4MMP13ADAMTS5 | |
| SCHEMBL18049268 | 0.91 | MMP2 (0.61) | MMP2MMP9ADAMTS4MMP13ADAMTS5 | |
| SCHEMBL19923004 | 0.91 | MMP2 (0.61) | MMP2MMP9ADAMTS4MMP13ADAMTS5 | |
| SCHEMBL8195568 | 0.90 | MMP2 (0.54) | MMP2MMP9ADAMTS4MMP13ADAMTS5 | |
| SCHEMBL8197720 | 0.90 | MMP2 (0.54) | MMP2MMP9ADAMTS4MMP13ADAMTS5 | |
| SCHEMBL12811750 | 0.90 | MMP2 (0.54) | MMP2MMP9ADAMTS4MMP13ADAMTS5 | |
| SCHEMBL30376399 | 0.90 | MMP2 (0.54) | MMP2MMP9ADAMTS4MMP13ADAMTS5 | |
| SCHEMBL18049375 | 0.89 | MMP2 (0.58) | MMP2MMP9ADAMTS4MMP13ADAMTS5 | |
| SCHEMBL7566084 | 0.89 | MMP2 (0.58) | MMP2MMP9ADAMTS4MMP13ADAMTS5 | |
| SCHEMBL29024842 | 0.87 | MMP2 (0.50) | MMP2MMP9ADAMTS4MMP13ITGAV |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2132174-A1 | META-SUBSTITUTED PHENYL SULFONYL AMIDES OF SECONDARY AMINO ACID AMIDES, THE PRODUCTION THEREOF, AND USE THEREOF AS MATRIPTASE INHIBITORS | The Medicines Company (Leipzig) GmbH (DE) | 2009-12-16 | — | — | EP | claimed |
| WO-2008107176-A1 | META-SUBSTITUTED PHENYL SULFONYL AMIDES OF SECONDARY AMINO ACID AMIDES, THE PRODUCTION THEREOF, AND USE THEREOF AS MATRIPTASE INHIBITORS | THE MEDICINES COMPANY (LEIPZIG) GMBH (DE) | 2008-09-12 | — | — | WO | claimed |
| CN-116323572-A | 3- (2- (benzo [ D ] thiazol-2-yl) -2- (phenylsulfonylamino) ethyl) benzamide derivatives and related compounds as TMPRSS2 inhibitors for the treatment of viral infections | 塔斯宾医疗公司 | 2023-06-23 | — | — | CN | disclosed |
| EP-4157825-A1 | 3-(2-(BENZO[D]THIAZOL-2-YL)-2-(PHENYLSUFONAMIDO)ETHYL)BENZIMIDAMIDE DERIVATIVES AND RELATED COMPOUNDS AS TMPRSS2 INHIBITORS FOR THE TREATMENT OF VIRAL INFECTIONS | Topspin Therapeutics, Inc. (US) | 2023-04-05 | — | — | EP | disclosed |
| US-8569313-B2 | Meta-substituted phenyl sulfonyl amides of secondary amino acid amides, the production thereof, and use thereof as matriptase inhibitors | THE MEDICINES COMPANY (LEIPZIG) GMBH (DE) | 2013-10-29 | — | — | US | disclosed |
| EP-2132174-B1 | META-SUBSTITUTED PHENYL SULFONYL AMIDES OF SECONDARY AMINO ACID AMIDES, THE PRODUCTION THEREOF, AND USE THEREOF AS MATRIPTASE INHIBITORS | MEDICINES CO LEIPZIG GMBH (DE) | 2012-02-01 | — | — | EP | disclosed |
| US-20100305090-A1 | META-SUBSTITUTED PHENYL SULFONYL AMIDES OF SECONDARY AMINO ACID AMIDES, THE PRODUCTION THEREOF, AND USE THEREOF AS MATRIPTASE INHIBITORS | THE MEDICINES COMPANY (LEIPZIG) GMBH (DE) | 2010-12-02 | — | — | US | disclosed |
| EP-2132174-A1 | META-SUBSTITUTED PHENYL SULFONYL AMIDES OF SECONDARY AMINO ACID AMIDES, THE PRODUCTION THEREOF, AND USE THEREOF AS MATRIPTASE INHIBITORS | The Medicines Company (Leipzig) GmbH (DE) | 2009-12-16 | — | — | EP | disclosed |
| WO-2008107176-A1 | META-SUBSTITUTED PHENYL SULFONYL AMIDES OF SECONDARY AMINO ACID AMIDES, THE PRODUCTION THEREOF, AND USE THEREOF AS MATRIPTASE INHIBITORS | THE MEDICINES COMPANY (LEIPZIG) GMBH (DE) | 2008-09-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100305090-A1 | META-SUBSTITUTED PHENYL SULFONYL AMIDES OF SECONDARY AMINO ACID AMIDES, THE PRODUCTION THEREOF, AND USE THEREOF AS MATRIPTASE INHIBITORS | MMP7, DNPEP, METAP1 | MMP2 15/4885MMP9 26/4885ADAMTS4 140/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.